Cory Kasimov Joins Evercore ISI as Senior Managing Director

Rhea-AI Summary

EVR: Evercore Announces Cory Kasimov as Senior Managing Director for Small-and Midcap Biotech Companies

Positive

• Cory Kasimov brings over two decades of research experience, including over 15 years as a senior biotech analyst at JPMorgan, to Evercore ISI.
• His research product and related events have consistently received recognition in Institutional Investor’s All-America Research poll.
• Mike Paliotta, CEO of Evercore ISI, expressed confidence in Kasimov's ability to strengthen the firm's healthcare research offering.
• Marc Harris, Evercore ISI's Director of Research, highlighted Kasimov's depth of experience and best-in-class content in the biotech domain.

Negative

• None.

NEW YORK--(BUSINESS WIRE)-- Evercore (NYSE: EVR) announced today that Cory Kasimov has joined Evercore ISI as a Senior Managing Director. Mr. Kasimov will lead coverage of small-and midcap biotech companies.

Mr. Kasimov’s two decades of research experience includes over 15 years as a senior biotech analyst at JPMorgan. His differentiated, actionable research product and related events have led to consistent recognition in Institutional Investor’s All-America Research poll, where Mr. Kasimov most recently repeated a top 3 ranking in the large-cap biotech sector and regularly achieves runner-up status in the SMID biotech category.

Mike Paliotta, Chief Executive Officer of Evercore ISI, said, “We’re proud of our track record of attracting top research talent to serve our clients. Cory will undoubtedly strengthen our already dominant healthcare research offering, and we look forward to having him on the team.”

Evercore ISI Director of Research Marc Harris added, “Cory is a great addition to our Research franchise. He brings depth, breadth of experience and best-in-class content to a complex research domain. We are confident his unique insights will help our clients navigate the investment landscape.”

“I am delighted to be joining a platform that is committed to providing the best research on the Street,” said Mr. Kasimov. "I am eager to join the Evercore ISI team and help clients identify investment ideas in the rapidly changing biotech world.”

About Evercore
Evercore (NYSE: EVR) is a premier global independent investment banking advisory firm. We are dedicated to helping our clients achieve superior results through trusted independent and innovative advice on matters of strategic significance to boards of directors, management teams and shareholders, including mergers and acquisitions, strategic shareholder advisory, restructurings and capital structure. Evercore also assists clients in raising public and private capital, delivers equity research and equity sales and agency trading execution, and provides wealth and investment management services to high-net-worth and institutional investors. Founded in 1995, the firm is headquartered in New York and maintains offices and affiliate offices in major financial centers in the Americas, Europe, the Middle East and Asia. For more information, please visit www.evercore.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231109833813/en/

Business:

Marc Harris

Evercore ISI Director of Research

+1.212.653.9048

Media:

Jamie Easton

Head of Communications & External Affairs

Communications@Evercore.com

Or

Shree Dhond / Zach Kouwe

Dukas Linden Public Relations

Evercore@DLPR.com

(646) 722-6531

Investor:

Katy Haber

Head of Investor Relations & ESG

InvestorRelations@Evercore.com

Source: Evercore

FAQ

What is the significance of Cory Kasimov joining Evercore ISI?

Cory Kasimov's addition as Senior Managing Director for small-and midcap biotech companies is expected to strengthen Evercore ISI's research offering in the healthcare sector.

What are Cory Kasimov's credentials?

Cory Kasimov has over two decades of research experience, including over 15 years as a senior biotech analyst at JPMorgan. He has consistently received recognition in Institutional Investor’s All-America Research poll.

What are the expectations from Cory Kasimov's role at Evercore ISI?

Cory Kasimov is expected to provide unique insights to help clients navigate the rapidly changing biotech investment landscape at Evercore ISI.